Open Access

Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients

  • Authors:
    • Citrawati Dyah Kencono Wungu
    • Mochamad Amin
    • S. Eriaty N. Ruslan
    • Priyo Budi Purwono
    • Ulfa Kholili
    • Ummi Maimunah
    • Poernomo Boedi Setiawan
    • Maria Inge Lusida
    • Soetjipto Soetjipto
    • Retno Handajani
  • View Affiliations

  • Published online on: September 9, 2019     https://doi.org/10.3892/br.2019.1239
  • Pages: 145-153
  • Copyright: © Kencono Wungu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In developing countries, including Indonesia, there is a high mortality rate associated with the progression of hepatitis B virus (HBV)‑associated chronic liver disease (CLD). The pathogenesis of HBV infection is influenced by viral and host factors. To determine potential associations between these factors, host single nucleotide polymorphisms (SNPs) on TNF‑α, TGF‑β1 and p53, HBV X gene mutation and HBV viral load were investigated in patients with HBV‑associated CLD in Surabaya, Indonesia. Sera were collected from 87 CLD patients with HBV infection. TNF‑α, TGF‑β1 and p53 SNPs were genotyped by PCR restriction fragment length polymorphism. The HBV X gene was sequenced and compared with reference strains to determine mutations and the viral load was measured using reverse transcription‑quantitative PCR. In Indonesian patients, no association between TNF‑α, TGF‑β1 and p53 SNPs and CLD or X gene mutation were identified. A total of 23% (20/87) of samples had HBV X gene mutations, including ten substitution types, one deletion and one insertion. Multinomial regression analysis revealed that the K130M/V131I mutations were correlated with CLD progression (OR, 7.629; 95% CI, 1.578‑36.884). Significant differences in viral load were found in HBV‑infected patients who had X gene mutations, such as R87W/G, I127L/T/N/S and K130M/V131I mutations (P<0.05). The presence of K130M and V131I mutations may be predictive for the progression of HBV‑associated CLD in Indonesia.

References

1 

Xu HZ, Liu YP, Guleng B and Ren JL: Hepatitis B virus-related hepatocellular carcinoma: Pathogenic mechanisms and novel therapeutic interventions. Gastrointest Tumors. 1:135–145. 2014.PubMed/NCBI View Article : Google Scholar

2 

Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E and Coppola N: Hepatitis B virus burden in developing countries. World J Gastroenterol. 21:11941–11953. 2015.PubMed/NCBI View Article : Google Scholar

3 

World Health Organization: Hepatitis B. 2018.

4 

Zeng Z: Human genes involved in hepatitis B virus infection. World J Gastroenterol. 20:7696–7706. 2014.PubMed/NCBI View Article : Google Scholar

5 

Mathew S, Abdel-Hafiz H, Raza A, Fatima K and Qadri I: Host nucleotide polymorphism in hepatitis B virus associated hepatocellular carcinoma. World J Hepatol. 8:485–498. 2016.PubMed/NCBI View Article : Google Scholar

6 

Xu XW, Lu MH and Tan DM: Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 11:52–56. 2005.PubMed/NCBI View Article : Google Scholar

7 

Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB and Kim JH: Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-α gene promoter polymorphisms. J Gastroenterol Hepatol. 21:1163–1169. 2006.PubMed/NCBI View Article : Google Scholar

8 

Hanafy SM and Abdo A: Impact of single nucleotide polymorphism of TGF-β1 gene (SNP-Codon10) on hepatocellular carcinoma risk in Egyptian patients following HCV infection. Aust J Basic Appl Sci. 5:1814–1821. 2011.

9 

Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R and Pirisi M: TGF-β1 genotypes in cirrhosis: Relationship with the occurrence of liver cancer. Cytokine. 44:256–261. 2008.PubMed/NCBI View Article : Google Scholar

10 

Schon H and Weiskirchen R: Immunomodulatory effects of transforming growth factor-β in the liver. Hepatobiliary Surg Nutr. 3:386–406. 2014.PubMed/NCBI View Article : Google Scholar

11 

Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: Insights into the etiology and pathogenesis of liver cancer. Oncogene. 26:2166–2176. 2007.PubMed/NCBI View Article : Google Scholar

12 

Wang Z, Gou W, Liu M, Sang W, Chu H and Zhang W: Expression of P53 and HSP70 in chronic hepatitis, liver cirrhosis, and early and advanced hepatocellular carcinoma tissues and their diagnostic value in hepatocellular carcinoma: An immunohistochemical study. Med Sci Monit. 21:3209–3215. 2015.PubMed/NCBI View Article : Google Scholar

13 

Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, et al: TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 33:1219–1224. 2012.PubMed/NCBI View Article : Google Scholar

14 

Hu S, Zhao L, Yang J and Hu M: The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: Evidence from a meta-analysis of 15 studies with 3,704 cases. Tumor Biol. 35:3647–3656. 2014.PubMed/NCBI View Article : Google Scholar

15 

Baumert TF, Thimme R and von Weizsäcker F: Pathogenesis of hepatitis B virus infection. World J Gastroenterol. 13:82–90. 2007.PubMed/NCBI View Article : Google Scholar

16 

You CR, Lee SW, Jang JW and Yoon SK: Update on hepatitis B virus infection. World J Gastroenterol. 20:13293–13305. 2014.PubMed/NCBI View Article : Google Scholar

17 

Geng M, Xin X, Bi LQ, Zhou LT and Liu XH: Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World J Gastroenterol. 21:10732–10738. 2015.PubMed/NCBI View Article : Google Scholar

18 

Zhang ZH, Wu CC, Chen XW, Li X, Li J and Lu MJ: Genetic variation of hepatitis B virus and its significance for pathogenesis. World J Gastroenterol. 22:126–144. 2016.PubMed/NCBI View Article : Google Scholar

19 

Guerrieri F, Belloni L, Pediconi N and Levrero M: Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis. 33:147–156. 2013.PubMed/NCBI View Article : Google Scholar

20 

Ayub A, Ashfaq UA and Haque A: HBV induced HCC: Major risk factors from genetic to molecular level. Biomed Res Int. 2013(810461)2013.PubMed/NCBI View Article : Google Scholar

21 

Abe A, Kazuaki I, Take AT, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M and Kohara M: Quantification of hepatitis B virus genomic DNA by real-time detection. J Clin Microbiol. 37:2899–2903. 1999.PubMed/NCBI

22 

Jamil K, Jayaraman A, Ahmad J, Joshi S and Yerra SK: TNF-alpha -308G/A and -238G/A polymorphisms and its protein network associated with type 2 diabetes mellitus. Saudi J Biol Sci. 24:1195–1203. 2016.PubMed/NCBI View Article : Google Scholar

23 

Chou HT, Chen CH, Tsai CH and Tsai FJ: Association between transforming growth factor-β1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J. 148:181–186. 2004.PubMed/NCBI View Article : Google Scholar

24 

Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF and Spitz MR: p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst. 94:681–690. 2002.PubMed/NCBI View Article : Google Scholar

25 

Lee JH, Han KH, Lee JM, Park JH and Kim HS: Impact of hepatitis B virus (HBV) X gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol. 18:914–921. 2011.PubMed/NCBI View Article : Google Scholar

26 

Nurainy N, Muljono DH, Sudoyo H and Marzuki S: Genetic study of hepatitis B virus in Indonesia reveals a new subgenotype of genotype B in east Nusa Tenggara. Arch Virol. 153:1057–1065. 2008.PubMed/NCBI View Article : Google Scholar

27 

Nagasaki F, Niitsuma H, Cervantes JG, Chiba M, Hong S, Ojima T, Ueno Y, Bondoc E, Kobayashi K, Ishii M and Shimosegawa T: Analysis of the entire nucleotide sequence of hepatitis B virus genotype B in the Philippines reveals a new subgenotype of genotype B. J Gen Virol. 87:1175–1180. 2006.PubMed/NCBI View Article : Google Scholar

28 

Horikita M, Itoh S, Yamamoto K, Shibayama T and Tsuda F: Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J Med Virol. 44:96–103. 1994.PubMed/NCBI View Article : Google Scholar

29 

Kim H, Lee SA and Kim BJ: X region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol. 22:5467–5478. 2016.PubMed/NCBI View Article : Google Scholar

30 

Fan W, Shi B, Wei H, Du G and Song S: Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes. 42:162–170. 2011.PubMed/NCBI View Article : Google Scholar

31 

Lin X, Xu X, Huang QL, Liu YQ, Zheng DL, Chen WN and Lin JY: Biological impacts of ‘hot-spot’ mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J Gastroenterol. 11:4703–4708. 2005.PubMed/NCBI View Article : Google Scholar

32 

Fatimawali   and Kepel B: Analisis mutasi gen protein X virus HBV pada penderita hepatitis B akut di manado. J LPPM Bid Sains Dan Teknol. 1:47–55. 2014.

33 

Banday MZ, Balkhi HM, Hamid Z, Sameer AS, Chowdri NA and Haq E: Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population-A case control study in a detailed perspective. Meta Gene. 9:128–136. 2016.PubMed/NCBI View Article : Google Scholar

34 

Li X, Liang C, Parkman V and Lv Z: The association between TNF-α 238A/G and 308A/G polymorphisms and juvenile idiopathic arthritis. Medicine (Baltimore). 97(e12883)2018.PubMed/NCBI View Article : Google Scholar

35 

Heidari Z, Moudi B, Mahmoudzadeh Sagheb H and Moudi M: Association of TNF-α gene polymorphisms with production of protein and susceptibility to chronic hepatitis B infection in the South East Iranian population. Hepat Mon. 16(e41984)2016.PubMed/NCBI View Article : Google Scholar

36 

Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, et al: Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 9:987–992. 2007.PubMed/NCBI View Article : Google Scholar

37 

Tavakolpour S and Sali S: Tumor necrosis factor-α-308 G/A polymorphisms and risk of hepatocellular carcinoma: A meta-analysis. Hepat Mon. 16(e33537)2016.PubMed/NCBI View Article : Google Scholar

38 

Xiao Q, Fu B, Chen P, Liu ZZ, Wang W and Ye Q: Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore). 95(e5609)2016.PubMed/NCBI View Article : Google Scholar

39 

Guo Y, Zang C, Li Y, Yuan L, Liu Q, Zhang L and Li S: Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis. Genet Test Mol Biomarkers. 17:814–820. 2013.PubMed/NCBI View Article : Google Scholar

40 

Qi P, Chen Y, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y and Gao CF: -509C>T polymorphism in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Cancer Immunol Immunother. 58:1433–1440. 2009.PubMed/NCBI View Article : Google Scholar

41 

Sümbül AT, Akkız H, Bayram S, Bekar A, Akgöllü E and Sandıkçı M: p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: A case-control study. Mol Biol Rep. 39:1639–1647. 2012.PubMed/NCBI View Article : Google Scholar

42 

Cai J, Cai Y, Ma Q, Chang F, Xu L, Zhang G and Guo X: Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan. Biomed Rep. 6:217–222. 2017.PubMed/NCBI View Article : Google Scholar

43 

Tian X, Dai S, Sun J, Jiang S and Jiang Y: Association between TP53 Arg72Pro polymorphism and leukemia risk: A meta-analysis of 14 case-control studies. Sci Rep. 6(24097)2016.PubMed/NCBI View Article : Google Scholar

44 

He T, Wu J, Chen Y and Zhang J: TP 53 polymorphisms and melanoma: A meta-analysis. J Cancer Res Ther. 11:409–414. 2015.PubMed/NCBI View Article : Google Scholar

45 

Lin YM, Shao J, Yin XH, Huang C, Jia XW, Yuan YD, Wu CJ, Zhen EM, Yao ZX, Zeng XT and Liu RH: Meta-analysis results on the association between TP53 codon 72 polymorphism with the susceptibility to oral cancer. Front Physiol. 9(1014)2018.PubMed/NCBI View Article : Google Scholar

46 

Chachá SGF, Gomes-Gouvêa MS, Malta FM, Ferreira SDC, Villanova MG, Souza FF, Teixeira AC2 Passos ADDC, Pinho JRR and Martinelli ALC: Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases. Mem Inst Oswaldo Cruz. 112:626–631. 2017.PubMed/NCBI View Article : Google Scholar

47 

Al-qahtani AA, Al-anazi MR, Nazir N, Ghai R, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, et al: Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients. Oncotarget. 8:105115–105125. 2017.PubMed/NCBI View Article : Google Scholar

48 

Datta S, Ghosh A, Dasgupta D, Ghosh A, Roychoudhury S, Roy G, Das S, Das K, Gupta S, Basu K, et al: Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: Characterization and impact on liver disease progression to hepatocellular carcinoma. PLoS One. 9(e110012)2014.PubMed/NCBI View Article : Google Scholar

49 

Kim HJ, Park JH, Jee Y, Lee SA, Kim H, Song BC, Yang S, Lee M, Yoon JH, Kim YJ, et al: Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J Med Virol. 80:1337–1343. 2008.PubMed/NCBI View Article : Google Scholar

50 

Li W, Goto K, Matsubara Y, Ito S, Muroyama R, Li Q and Kato N: The characteristic changes in hepatitis B virus X region for hepatocellular carcinoma: A comprehensive analysis based on global data. PLoS One. 10(e0125555)2015.PubMed/NCBI View Article : Google Scholar

51 

Wen J, Song C, Jiang D, Jin T, Dai J, Zhu L, An J, Liu Y, Ma S, Qin N, et al: Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: A multi-centre case-control study. Nature. 5(16489)2015.PubMed/NCBI View Article : Google Scholar

52 

Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X, et al: HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 87:12176–12186. 2013.PubMed/NCBI View Article : Google Scholar

53 

Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu R, Shen Q, Lu W, Du Y, Zhao J, et al: Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma. Hepatology. 57:2369–2377. 2013.PubMed/NCBI View Article : Google Scholar

54 

Ledesma MM, Galdame O, Bouzas B, Tadey L, Livellara B, Giuliano S, Viaut M, Paz S, Fainboim H, Gadano A, et al: Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus. Int J Infect Dis. 15:e314–e320. 2011.PubMed/NCBI View Article : Google Scholar

55 

Chu CJ, Hussain M and Lok AS: Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology. 36:1408–1415. 2002.PubMed/NCBI View Article : Google Scholar

56 

Harkisoen S, Arends JE, van den Hoek JA, Whelan J, van Erpecum KJ, Boland GJ and Hoepelman AI: Historic and current hepatitis B viral DNA and quantitative HBsAg level are not associated with cirrhosis in non-Asian women with chronic hepatitis B. Int J Infect Dis. 29:133–138. 2014.PubMed/NCBI View Article : Google Scholar

57 

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS and Kao JH: High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 142:1140–1149.e3. 2012.PubMed/NCBI View Article : Google Scholar

58 

Tu T, Budzinska MA, Shackel NA and Urban S: HBV DNA integration: Molecular mechanisms and clinical implications. Viruses. 9(E75)2017.PubMed/NCBI View Article : Google Scholar

59 

Leung NW, Tam JS, Lau GT, Leung TW, Lau WY and Li AK: Hepatitis B virus DNA in peripheral blood leukocytes a comparison between hepatocellular carcinoma and Other hepatitis B virus-related chronic liver diseases. Cancer. 73:1143–1148. 1994.PubMed/NCBI View Article : Google Scholar

60 

Barbini L, Tadey L, Fernandez S, Bouzas B and Campos R: Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients. Virol J. 9(131)2012.PubMed/NCBI View Article : Google Scholar

61 

Ghabeshi S, Sharifi Z, Hosseini SM and Mahmoodian Shooshtari M: Correlation between viral load of HBV in chronic hepatitis B patients and precore and basal core promoter mutations. Hepat Mon. 13(e7415)2013.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

October 2019
Volume 11 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P.B., Kholili, U., Maimunah, U. ... Handajani, R. (2019). Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomedical Reports, 11, 145-153. https://doi.org/10.3892/br.2019.1239
MLA
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P. B., Kholili, U., Maimunah, U., Setiawan, P. B., Lusida, M. I., Soetjipto, S., Handajani, R."Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients". Biomedical Reports 11.4 (2019): 145-153.
Chicago
Kencono Wungu, C., Amin, M., N. Ruslan, S., Purwono, P. B., Kholili, U., Maimunah, U., Setiawan, P. B., Lusida, M. I., Soetjipto, S., Handajani, R."Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients". Biomedical Reports 11, no. 4 (2019): 145-153. https://doi.org/10.3892/br.2019.1239